TY  - JOUR

T1  - Matrix-directed therapy losartan to identify the effect on the bone resorption marker carboxy-terminal crosslink of type I collagen telopeptide (CTX) in older adolescents and adults with osteogenesis imperfecta recruited from secondary care sites: the ‘MOI-A’ study; a randomised, phase 2/pilot, dose-escalating trial

JO  - BMJ Open

UR  - https://doi.org/10.1136/bmjopen-2025-107243

PY  - 2025/12/07

AU  - Haji Sadeghi M

AU  - Cohen J

AU  - Williams B

AU  - Wilkinson A

AU  - Sumpter S

AU  - Simms L

AU  - Huang C

AU  - Pugh K

AU  - Heath C

AU  - Sangiorgi L

AU  - Gurioli F et al

ED  - 

DO  - DOI: 10.1136/bmjopen-2025-107243

PB  - BMJ

VL  - 15

IS  - 12

SP  - e107243

EP  - e107243

Y2  - 2026/02/05

ER  -